Bacterial meningitis in malawian infants <2 months of age: Etiology and susceptibility to World Health Organization first-line antibiotics

Pediatric Infectious Disease Journal

Volumn 33, Issue 6, 2014, Pages 560-565

  Swann, Olivia ^a,b   Everett, Dean B ^a,c   Furyk, Jeremry S ^d   Harrison, Ewen M ^e   Msukwa, Malango T ^a   Heyderman, Robert S ^a,f   Molyneux, Elizabeth M ^a  

^a UNIVERSITY OF MALAWI   (Malawi)

^b Ashworth Laboratories   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d TOWNSVILLE HOSPITAL   (Australia)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

Africa; drug resistance; infant; meningitis; microbial; Newborn

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; ERYTHROMYCIN; GENTAMICIN; PENICILLIN DERIVATIVE; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; BACTERIUM CULTURE; BACTERIUM ISOLATE; CEREBROSPINAL FLUID ANALYSIS; DRUG SCREENING; FISHER EXACT TEST; GRAM NEGATIVE BACTERIUM; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALAWI; NEWBORN; PRIORITY JOURNAL; SALMONELLA; SALMONELLA ENTERICA; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; WORLD HEALTH ORGANIZATION; CEREBROSPINAL FLUID; DRUG EFFECTS; ISOLATION AND PURIFICATION; MENINGITIS, BACTERIAL; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; CEFTRIAXONE; GENTAMICINS; HUMANS; INFANT, NEWBORN; MALAWI; MENINGITIS, BACTERIAL; MICROBIAL SENSITIVITY TESTS; SALMONELLA ENTERICA; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE;

EID: 84901507367     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000210     Document Type: Article

References (45)

1. Black RE Cousens S Johnson HL et al.; Child Health Epidemiology Reference Group of WHO and UNICEF. Global regional and national causes of child mortality in 2008: a systematic analysis. Lancet. 2010;375:1969-1987.
2. Mwaniki MK Talbert AW Njuguna P et al. Clinical indicators of bacterial meningitis among neonates and young infants in rural Kenya. BMC Infect Dis. 2011;11:301.
3. Muhe L Tilahun M Lulseged S et al. Etiology of pneumonia sepsis and meningitis in infants younger than three months of age in Ethiopia. Pediatr Infect Dis J. 1999;18(10 suppl):S56-S61. (Pubitemid 29485358)
4. Gebremariam A. Neonatal meningitis in Addis Ababa: a 10-year review. Ann Trop Paediatr. 1998;18:279-283. (Pubitemid 28537600)
5. English M Ngama M Musumba C et al. Causes and outcome of young infant admissions to a Kenyan district hospital. Arch Dis Child. 2003;88:438-443. (Pubitemid 36566733)
6. Laving AM Musoke RN Wasunna AO et al. Neonatal bacterial meningitis at the newborn unit of Kenyatta National Hospital. East Afr Med J. 2003;80:456-462. (Pubitemid 41184963)
7. Talbert AW Mwaniki M Mwarumba S et al. Invasive bacterial infections in neonates and young infants born outside hospital admitted to a rural hos pital in Kenya. Pediatr Infect Dis J. 2010;29:945-949.
8. Molyneux E Walsh A Phiri A et al. Acute bacterial meningitis in children admitted to the Queen Elizabeth Central Hospital Blantyre Malawi in 1996-97. Trop Med Int Health. 1998;3:610-618.
9. Milledge J Calis JC Graham SM et al. Aetiology of neonatal sepsis in Blantyre Malawi: 1996-2001. Ann Trop Paediatr. 2005;25:101-110.
10. Nathoo KJ Pazvakavamba I Chidede OS et al. Neonatal meningitis in Harare Zimbabwe: a 2-year review. Ann Trop Paediatr. 1991;11:11-15.
11. Mulholland EK Ogunlesi OO Adegbola RA et al. Etiology of serious infections in young Gambian infants. Pediatr Infect Dis J. 1999;18(10 suppl):S35-S41. (Pubitemid 29485355)
12. Campagne G Schuchat A Djib o S et al. Epidemiology of bacterial meningitis in Niamey Niger 1981-96. Bull World Health Organ. 1999;77:499-508.
13. Longe AC Omene JA Okolo AA. Neonatal meningitis in Nigerian infants. Acta Paediatr Scand. 1984;73:477-481. (Pubitemid 14084691)
14. Airede AI. Neonatal bacterial meningitis in the middle belt of Nigeria. Dev Med Child Neurol. 1993;35:424-430. (Pubitemid 23133202)
15. Airede KI Adeyemi O Ibrahim T. Neonatal bacterial meningitis and dexamethasone adjunctive usage in Nigeria. Niger J Clin Pract. 2008;11:235-245.
16. Coovadia YM Mayosi B Adhikari M et al. Hospital-acquired neonatal bacterial meningitis: the impacts of cefotaxime usage on mortality and of amikacin usage on incidence. Ann Trop Paediatr. 1989;9:233-239. (Pubitemid 20037551)
17. Adhikari M Coovadia YM Singh DA 4-year study of neonatal meningitis: clinical and microbiological findings J Trop Pediatr 1995 41 81-85.
18. Nel E. Neonatal meningitis: mortality cerebrospinal fluid and microbiological findings. J Trop Pediatr. 2000;46:237-239. (Pubitemid 30614561)
19. Dagnew AF Cunnington MC Dube Q et al. Variation in reported neonatal group B streptococcal disease incidence in developing countries. Clin Infect Dis. 2012;55:91-102.
20. Edmond KM Kortsalioudaki C Scott S et al. Group B streptococcal disease in infants aged younger than 3 months: s ystematic review and meta-analysis. Lancet. 2012;379:547-556.
21. The World Health Organization Young Infants Study Group. Conclusions from the WHO multicenter study of serious infections in young infants. Pediatr Infect Dis J. 1999;18:S32-S34.
22. World Health Organization UNICEF. Management of the Child With a Serious Infection or Severe Malnutrition: Guidelines for Care at the First-referral Level in Developing Co untries. Geneva: World Health Organization; 2000.
23. World Health Organization UNAIDS. Managing Newborn Problems a Guide for Doctors Nurses and Midwives. Geneva: World Health Organization; 2003.
24. World Health Organization UNICEF. Handbook: IMCI Integrated Management of Childhood Illness. Geneva: World Health Organization; 2005.
25. World Health Organization. Pocket Book of Hospital Care for Children: Guidelines for the Management of Common Illness With Limited Resources. Geneva: World Health Organization; 2005.
26. World Health Organization UNICEF. Integrated Management of Childhood Illness (Chart Booklet). Geneva: World Health Organization; 2008.
27. World Health Organisation UNICEF. Integrated Management of Childhood Illness for High HIV Settings (Chart Booklet). Geneva: World Health Organization; 2008.
28. World Health Organization UNICEF. Integrated Management of Childhood Illness. ICMI Adaptation Guide-Part 2c-Technical Basis for Adapting the Clinical Guidelines Feeding Recommendations and Local Terms. Geneva: World Health Organization ; 2002.
29. Gordon MA Graham SM Walsh AL et al. Epidemics of invasive Salmonella enterica serovar enteritidis and S. enterica Serovar typhimurium infection associated with multidrug resistance among adults and children in Malawi. Clin Infect Dis. 2008;46:963-969. (Pubitemid 351589858)
30. Bronzan RN Taylor TE Mwenechanya J et al. Bacteremia in Malawian children with severe malaria: prevalence etiology HIV coinfection and outcome. J Infect Dis. 2007;195:895-904. (Pubitemid 46363936)
31. Barrow G Feltham R. Cowan and Steel's Manual for the Identification of Medical Bacteria. Third edition. Cambridge UK: Cambridge University Press; 1993.
32. Andrews JM. The development of the BSAC standardized method of disc diffusion testing. J Antimicrob Chemother. 2001;48 (suppl 1):29-42.
33. Everett DB Mukaka M Denis B et al. Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi. PLoS One. 2011;6:e17765.
34. Haffejee IE Bhana RH Coovadia YM et al. Neonatal group B streptococcal infections in Indian (Asian) babies in South Africa. J Infect. 1991;22:225-231.
35. Johri AK Paoletti LC Glaser P et al. Group B Streptococcus: global incidence and vaccine development. Nat Rev Microbiol. 2006;4:932-942. (Pubitemid 44768255)
36. Graham SM Molyneux EM Walsh AL et al. Nontyphoidal Salmonella infections of children in tropical Africa. Pediatr Infect Dis J. 2000;19: 1189-1196. (Pubitemid 32003365)
37. Graham SM Wal sh AL Molyneux EM et al. Clinical presentation of non-typhoidal Salmonella bacteraemia in Malawian children. Trans R Soc Trop Med Hyg. 2000;94:310-314. (Pubitemid 30406567)
38. Price EH de Louvois J Workman MR. Antibiotics for Salmonella meningitis in children J Antimicrob Chemother. 2000 46 653-655.
39. McCormick DW Molyneux EM. Bacterial meningitis and Haemophilus influenzae type b conjugate vaccine Malawi. Emerg Infect Dis. 2011;17: 688-690.
40. English M Mohammed S Ross A et al. A randomised controlled trial of once daily and multi-dose daily gentamicin in young Kenyan infants. Arch Dis Child. 2004;89:665-669.
41. Cherubin CE Eng RH Norrby R et al. Penetration of newer cephalosporins into cerebrospinal fluid. Rev Infect Dis. 1989;11:526-548.
42. Gray KJ Wilson LK Phiri A et al. Identification and characterization of ceftriaxone resistance and extended-spectrum beta-lactamases in Malawian bacteraemic Enterobacteriaceae. J Antimicrob Chemother. 2006;57:661-665.
43. Bradley JS Wassel RT Lee L et al. Intravenous ceftriaxone and calcium in the neonate: assessing the risk for cardiopulmonary adverse events. Pediatrics. 2009;123:e609-e613.
44. Alvarez-Coca González J Cebrero García M Vecilla Rivelles MC et al. [Transient biliary lithiasis associated with the use of ceftriaxone]. An Esp Pediatr. 2000;53:366-368. (Pubitemid 32390739)
45. Martin E Fanconi S Kälin P et al. Ceftriaxone-bilirubin-albumin interactions in the neonate: an in vivo study. Eur J Pediatr. 1993;152:530-534. (Pubitemid 23166195)